Pediatric injuries attributable to falls from windows in the United States in 1990-2008

Vaughn A Harris1, Lynne M Rochette, Gary A Smith

  • 1Center for Injury Research and Policy, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio 43205, USA.

Pediatrics
|August 24, 2011
PubMed

Insights

Pediatric window falls cause significant injuries, with younger children and hard surface impacts leading to more severe outcomes. Prevention programs are crucial to address this public health issue.

Area of Science:

  • Public Health
  • Epidemiology
  • Pediatric Injury Prevention

Background:

  • Falls from windows represent a significant cause of pediatric injuries.
  • Understanding the epidemiological characteristics of these injuries is essential for effective prevention.

Purpose of the Study:

  • To investigate the epidemiological features of pediatric injuries resulting from falls from windows.
  • To identify risk factors and trends associated with window fall injuries in children.

Main Methods:

  • Utilized the National Electronic Injury Surveillance System (NEISS) database.
  • Analyzed emergency department (ED) data for pediatric injury cases related to window falls from 1990 to 2008.

Main Results:

  • An estimated 98,415 children were treated in US EDs for window fall injuries.
  • Younger children (0-4 years) and falls onto hard surfaces were associated with higher rates of head injuries and hospitalization.
  • A significant decrease in the annual injury rate was observed over the study period.

Conclusions:

  • Window fall-related injuries constitute a critical pediatric public health concern.
  • Enhanced prevention strategies and innovative programs are necessary to reduce the incidence and severity of these injuries.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...